Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua J Meeks

Showing results (21-30 of 208) with videos related to

Pageof 21
Sort By:
The Urologic Clinics of North America|November 5, 2013
Office-based management of nonmuscle invasive bladder cancerJoshua J Meeks, Harry W Herr
The Journal of Urology|June 19, 2016
Editorial CommentDaniel T Oberlin, Joshua J Meeks
The Journal of Urology|June 4, 2017
Editorial CommentRichard S Matulewicz, Joshua J Meeks
JAMA|August 3, 2016
JAMA PATIENT PAGE. Testicular MassRichard S Matulewicz, Joshua J Meeks
Cancer Cell|November 15, 2017
Molecular Landscape of Non-Muscle Invasive Bladder CancerJoshua J Meeks, Seth P Lerner
BJU International|July 25, 2013
High-risk prostate cancer: too risky for the robotic learning curveJoshua J Meeks, James A Eastham
World Journal of Urology|June 21, 2014
Application of the 2013 American Urological Association early detection of prostate cancer guideline: who will we miss?Gregory B Auffenberg, Joshua J Meeks
The Journal of Urology|April 22, 2018
Editorial CommentJoshua J Meeks, Alexander P Glaser
European Urology|January 10, 2012
Robotic prostatectomy: the rise of the machines or judgment dayJoshua J Meeks, James A Eastham
European Urology|April 22, 2020
Immune Signatures Dominate Molecular Subtyping to Predict Response to Neoadjuvant ImmunotherapyJoshua J Meeks, A Gordon Robertson
Pageof 21

Showing results (21-30 of 208) with videos related to

Sort By:
Pageof 21
The Urologic Clinics of North America|November 5, 2013
Office-based management of nonmuscle invasive bladder cancerJoshua J Meeks, Harry W Herr
The Journal of Urology|June 19, 2016
Editorial CommentDaniel T Oberlin, Joshua J Meeks
The Journal of Urology|June 4, 2017
Editorial CommentRichard S Matulewicz, Joshua J Meeks
JAMA|August 3, 2016
JAMA PATIENT PAGE. Testicular MassRichard S Matulewicz, Joshua J Meeks
Cancer Cell|November 15, 2017
Molecular Landscape of Non-Muscle Invasive Bladder CancerJoshua J Meeks, Seth P Lerner
BJU International|July 25, 2013
High-risk prostate cancer: too risky for the robotic learning curveJoshua J Meeks, James A Eastham
World Journal of Urology|June 21, 2014
Application of the 2013 American Urological Association early detection of prostate cancer guideline: who will we miss?Gregory B Auffenberg, Joshua J Meeks
The Journal of Urology|April 22, 2018
Editorial CommentJoshua J Meeks, Alexander P Glaser
European Urology|January 10, 2012
Robotic prostatectomy: the rise of the machines or judgment dayJoshua J Meeks, James A Eastham
European Urology|April 22, 2020
Immune Signatures Dominate Molecular Subtyping to Predict Response to Neoadjuvant ImmunotherapyJoshua J Meeks, A Gordon Robertson
Pageof 21